🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

6 recruiting trials

for Recurrent Respiratory Papillomatosis

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP) NCT06412172n/a1 site📍 New Haven Massachusetts General Hospital Merck IIT: RRP Pembro and Lenvatinib NCT04645602Phase 21 site📍 New Haven Yale University · Tests: Lenvatinib, Pembrolizumab Zopa Retreatment and Vector Shedding in Adults With RRP NCT06538480Phase 43 sites📍 Atlanta📍 Bethesda📍 Cincinnati Precigen, Inc · Tests: Zopapogene imadenovec (Zopa) Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ") NCT06000527n/a1 site📍 Paris Imagine Institute Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients NCT07317154Phase 11 site📍 Scottsdale Mayo Clinic · Tests: Autologous HPV6 E6-and E7-derived peptide-loaded dendritic cell
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy